Shopping Cart 0
Cart Subtotal
USD 0

Daiichi Sankyo Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 750

Details

Summary

Daiichi Sankyo Inc (Daiichi Sankyo), a subsidiary of Daiichi Sankyo Company Ltd is a healthcare products provider that discovers and develops medicines for cardiovascular and metabolic disorders. The company's products comprise amlodipine, laninamivir, prasugrel, olmesartan esomeprazole, carvedilol and vemurafenib. It develops medicines for various therapeutic classes, such as atherosclerosis, heart disease, hypertension, diabetes and hyperlipidemia. Daiichi Sankyo develops statin class of lipid-lowering agents and glitazone that revolutionized long-term control of type 2 diabetes. The company operates in Atlanta, Chicago, Charlotte, Dallas, Phoenix and Basking Ridge. Daiichi Sankyo is headquartered in Parsippany, New Jersey, the US.

Daiichi Sankyo Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Daiichi Sankyo Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Daiichi Sankyo Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Daiichi Sankyo Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Daiichi Sankyo Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Daiichi Sankyo Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Daiichi Sankyo Inc, Pharmaceuticals & Healthcare, Deal Details 10

Partnerships 10

AstraZeneca Enters into Commercialization Agreement with Daiichi Sankyo for Movantik 10

Merger 11

Daiichi Sankyo to Merge with Asubio Pharma 11

Licensing Agreements 12

Menarini Enters into Licensing Agreement with Daiichi Sankyo 12

Daiichi Sankyo to Enter into Licensing Agreement with Inspirion Delivery Sciences 13

Daiichi Sankyo Enters into Licensing Agreement with Inspirion Delivery Sciences 14

Daiichi Sankyo Inc-Key Competitors 15

Daiichi Sankyo Inc-Key Employees 16

Daiichi Sankyo Inc-Locations And Subsidiaries 17

Head Office 17

Other Locations & Subsidiaries 17

Recent Developments 18

Corporate Communications 18

Dec 14, 2017: Winners of 10th Manpei Suzuki International Prize for Diabetes Research and 11th Manpei Suzuki Prize for Diabetes Care and Education Announced 18

Legal and Regulatory 20

Jun 06, 2018: Daiichi Sankyo's U.S. Products Liability Litigation Settlement Program Moves Forward; More than 97 Percent of Eligible Litigants and Claimants Opt In 20

Apr 05, 2018: Fortis to take on Daiichi in case to block its Rs 3,900-crore deal with Manipal Health 21

Aug 01, 2017: Daiichi Sankyo Announces Settlement Agreement on U.S. Products Liability Litigation 22

Other Significant Developments 23

Nov 20, 2017: Daiichi Sankyo, Launches CommitmentsinPainCare.com 23

May 10, 2017: Daiichi Sankyo Adds the Source-to-Pay Catalyst from Zycus to Boost Its Procurement Performance 24

Apr 03, 2017: Daiichi Sankyo Announces Sale of Pharmaceutical Packaging Plant in Bethlehem, PA 25

Appendix 26

Methodology 26

About GlobalData 26

Contact Us 26

Disclaimer 26


List Of Figure

List of Figures

Daiichi Sankyo Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Daiichi Sankyo Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Daiichi Sankyo Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Daiichi Sankyo Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Daiichi Sankyo Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Daiichi Sankyo Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Daiichi Sankyo Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Daiichi Sankyo Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

Daiichi Sankyo Inc, Pharmaceuticals & Healthcare, Key Facts 2

Daiichi Sankyo Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Daiichi Sankyo Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Daiichi Sankyo Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Daiichi Sankyo Inc, Deals By Therapy Area, 2012 to YTD 2018 8

Daiichi Sankyo Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

AstraZeneca Enters into Commercialization Agreement with Daiichi Sankyo for Movantik 10

Daiichi Sankyo to Merge with Asubio Pharma 11

Menarini Enters into Licensing Agreement with Daiichi Sankyo 12

Daiichi Sankyo to Enter into Licensing Agreement with Inspirion Delivery Sciences 13

Daiichi Sankyo Enters into Licensing Agreement with Inspirion Delivery Sciences 14

Daiichi Sankyo Inc, Key Competitors 15

Daiichi Sankyo Inc, Key Employees 16

Daiichi Sankyo Inc, Other Locations 17

Daiichi Sankyo Inc, Subsidiaries 17

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Daiichi Sankyo Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

Daiichi Sankyo Inc (Daiichi Sankyo), a subsidiary of Daiichi Sankyo Company Ltd is a healthcare products provider that discovers and develops medicines for cardiovascular and metabolic disorders. The company's products comprise amlodipine, laninamivir, prasugrel, olmesartan esomeprazole, carvedilol and vemurafenib. It develops medicines for various therapeutic classes, such as atherosclerosis, heart disease, hypertension, diabetes and hyperlipidemia. Daiichi Sankyo develops statin class of lipid-lowering agents and glitazone that revolutionized long-term control of type 2 diabetes. The company operates in Atlanta, Chicago, Charlotte, Dallas, Phoenix and Basking Ridge. Daiichi Sankyo is headquartered in Parsippany, New Jersey, the US.

Daiichi Sankyo Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Daiichi Sankyo Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Daiichi Sankyo Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Daiichi Sankyo Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Daiichi Sankyo Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Daiichi Sankyo Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Daiichi Sankyo Inc, Pharmaceuticals & Healthcare, Deal Details 10

Partnerships 10

AstraZeneca Enters into Commercialization Agreement with Daiichi Sankyo for Movantik 10

Merger 11

Daiichi Sankyo to Merge with Asubio Pharma 11

Licensing Agreements 12

Menarini Enters into Licensing Agreement with Daiichi Sankyo 12

Daiichi Sankyo to Enter into Licensing Agreement with Inspirion Delivery Sciences 13

Daiichi Sankyo Enters into Licensing Agreement with Inspirion Delivery Sciences 14

Daiichi Sankyo Inc-Key Competitors 15

Daiichi Sankyo Inc-Key Employees 16

Daiichi Sankyo Inc-Locations And Subsidiaries 17

Head Office 17

Other Locations & Subsidiaries 17

Recent Developments 18

Corporate Communications 18

Dec 14, 2017: Winners of 10th Manpei Suzuki International Prize for Diabetes Research and 11th Manpei Suzuki Prize for Diabetes Care and Education Announced 18

Legal and Regulatory 20

Jun 06, 2018: Daiichi Sankyo's U.S. Products Liability Litigation Settlement Program Moves Forward; More than 97 Percent of Eligible Litigants and Claimants Opt In 20

Apr 05, 2018: Fortis to take on Daiichi in case to block its Rs 3,900-crore deal with Manipal Health 21

Aug 01, 2017: Daiichi Sankyo Announces Settlement Agreement on U.S. Products Liability Litigation 22

Other Significant Developments 23

Nov 20, 2017: Daiichi Sankyo, Launches CommitmentsinPainCare.com 23

May 10, 2017: Daiichi Sankyo Adds the Source-to-Pay Catalyst from Zycus to Boost Its Procurement Performance 24

Apr 03, 2017: Daiichi Sankyo Announces Sale of Pharmaceutical Packaging Plant in Bethlehem, PA 25

Appendix 26

Methodology 26

About GlobalData 26

Contact Us 26

Disclaimer 26


List Of Figure

List of Figures

Daiichi Sankyo Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Daiichi Sankyo Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Daiichi Sankyo Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Daiichi Sankyo Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Daiichi Sankyo Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Daiichi Sankyo Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Daiichi Sankyo Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Daiichi Sankyo Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

Daiichi Sankyo Inc, Pharmaceuticals & Healthcare, Key Facts 2

Daiichi Sankyo Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Daiichi Sankyo Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Daiichi Sankyo Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Daiichi Sankyo Inc, Deals By Therapy Area, 2012 to YTD 2018 8

Daiichi Sankyo Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

AstraZeneca Enters into Commercialization Agreement with Daiichi Sankyo for Movantik 10

Daiichi Sankyo to Merge with Asubio Pharma 11

Menarini Enters into Licensing Agreement with Daiichi Sankyo 12

Daiichi Sankyo to Enter into Licensing Agreement with Inspirion Delivery Sciences 13

Daiichi Sankyo Enters into Licensing Agreement with Inspirion Delivery Sciences 14

Daiichi Sankyo Inc, Key Competitors 15

Daiichi Sankyo Inc, Key Employees 16

Daiichi Sankyo Inc, Other Locations 17

Daiichi Sankyo Inc, Subsidiaries 17

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Daiichi Sankyo Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.